News
The move reveals both the power of philanthropic groups to sway legislators and a split in the administration’s coalition.
An obesity drug from Hengrui Pharma and Kailera Therapeutics succeeded in a late-stage trial in China, while Anne Wojcicki’s ...
Seven biotech unicorns are advancing AI-powered drug discovery and development—but must contend with a difficult investing ...
Illimis Therapeutics’ Series B round was led by Korean venture capital firm DSC Investment. Seoul-based Illimis Therapeutics has raised 58 billion won ($42 million) to fund its research into ...
President Trump said he was likely to impose tariffs on pharmaceuticals as soon as the end of the month, starting with a "low ...
Illustrating its confidence in its proprietary products, the Southern California company has announced an ambitious plan to ...
Photo: Alamy President Donald Trump said Tuesday that pharmaceutical companies could soon face new tariffs, with initial ...
GLP-1 anti-obesity medications are linked with improvements in testosterone levels and health outcomes for men with obesity or type 2 diabetes, researchers reported in San Francisco at ENDO 2025, the ...
Eli Lilly’s stock closed at $771.75, slipping 3.45% and lagging the broader market. The company’s shares fell despite outperforming the medical sector over the past month. Analysts eagerly await its ...
Trump pharma and chip tariffs may start this month, sparking price hikes, inflation, and global trade ripples.
President Donald Trump is keeping up the pace with seemingly a new tariff development every day. This time, he flagged that ...
Medical schools must make microbiology a prerequisite — to prepare students not just for school but for practicing medicine.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results